 Testicular carcinoma patients positive risk human immunodeficiency virus Patients acquired immunodeficiency syndrome risk certain malignancies immunodeficiency syndrome testicular cancer young men potential complications immunodeficiency syndrome significant concern question retrospective review cases testicular cancer period patients human immunodeficiency virus infection human immunodeficiency virus risk groups cases stage II disease seminoma teratocarcinoma embryonal cell carcinoma teratoma clinical presentations patients comparable patients human immunodeficiency virus risk factors majority patients standard therapy orchiectomy lymphadenectomy radiation therapy chemotherapy stage pathological subtype Patients course radiation therapy Pneumocystis carinii pneumonia patients complete remission none testicular cancer treatment patients immunosuppression surveillance orchiectomy acquired immunodeficiency syndrome patients stage majority patients human immunodeficiency virus infection standard therapy